| A comprehensive pan-cancer molecular study of gynecologic and breast cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer cell 33 (4), 690-705. e9, 2018 | 581 | 2018 |
| A new frontier in personalized cancer therapy: mapping molecular changes K Kasaian, SJM Jones Future oncology 7 (7), 873-894, 2011 | 16 | 2011 |
| A pan-cancer analysis of enhancer expression in nearly 9000 patient samples H Chen, C Li, X Peng, Z Zhou, JN Weinstein, SJ Caesar-Johnson, ... Cell 173 (2), 386-399. e12, 2018 | 287 | 2018 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 152 | 2018 |
| Abstract LB-173: Genome analysis informs chemotherapy decision-making in patients with advanced malignancies. JJ Laskin, K Gelmon, H Lim, D Renouf, S Yip, D Huntsman, A Tinker, ... Cancer Research 73 (8_Supplement), LB-173-LB-173, 2013 | | 2013 |
| Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development M Gasparetto, S Sekulovic, C Brocker, P Tang, A Zakaryan, P Xiang, ... Experimental Hematology, 2011 | 45 | 2011 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2827 | 2018 |
| Annotating the regulatory genome SB Montgomery, K Kasaian, SJM Jones, OL Griffith Computational Biology of Transcription Factor Binding, 313-349, 2010 | 2 | 2010 |
| Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... nature genetics 55 (6), 1076-1076, 2023 | 2 | 2023 |
| Author Correction: Pan-cancer analysis of whole genomes Nature 614 (7948), E39-E39, 2023 | 1 | 2023 |
| Author Correction: Pan-cancer analysis of whole genomes (Nature,(2020), 578, 7793,(82-93), 10.1038/s41586-020-1969-6) LA Aaltonen, F Abascal, A Abeshouse, H Aburatani, DJ Adams, ... Nature 614 (7948), E39, 2023 | | 2023 |
| Author Correction: The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 614 (7948), E42-E42, 2023 | 2 | 2023 |
| Biallelic alteration and dysregulation of the hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney R Mehra, P Vats, M Cieslik, X Cao, F Su, S Shukla, AM Udager, R Wang, ... Cancer discovery 6 (11), 1258-1266, 2016 | 74 | 2016 |
| Bioinformatic analyses approaches for personalized oncogenomics K Kasaian, Y Shen, S Leelakumari, P Eirew, YY Li, E Pleasance, ... Cancer Research 74 (19_Supplement), 5340-5340, 2014 | | 2014 |
| Bioinformatics for cancer genomics K Kasaian, YY Li, SJM Jones Cancer Genomics: From Bench to Personalized Medicine 1, 134-152, 2013 | 4 | 2013 |
| Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors BL Marini, LL Benitez, AH Zureick, R Salloum, AC Gauthier, J Brown, ... Translational Research 188, 27. e1-27. e14, 2017 | 16 | 2017 |
| Breast cancer whole genomes link homologous recombination deficiency (HRD) with therapeutic outcomes EY Zhao, Y Shen, E Pleasance, K Kasaian, MR Jones, C Ch'ng, C Reisle, ... Cancer Research 77 (13_Supplement), 2473-2473, 2017 | | 2017 |
| Cancer Genomics K Kasaian, YY Li, SJM Jones | 1 | 2014 |
| Cancer Genomics: Chapter 9. Bioinformatics for Cancer Genomics K Kasaian, YY Li, SJM Jones Elsevier Inc. Chapters, 2013 | | 2013 |
| Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy N Chooback, Y Shen, M Jones, K Kasaian, M Martin, T Ng, T Thomson, ... Current Oncology 24 (3), 251-254, 2017 | 22 | 2017 |
